5 mg
CoA on request
Metabolic Research
Semaglutide
Long-acting GLP-1 receptor agonist analog supplied for metabolic pathway and incretin-signaling research models.
$129
View
Dual incretin-pathway research peptide for laboratory study of GIP and GLP-1 receptor signaling.
| Size | 5 mg |
|---|---|
| Form | Lyophilized powder |
| Purity / documentation | Lot-specific Certificate of Analysis available on request |
| CAS | 2023788-19-2 |
| Molecular weight | 4813.5 g/mol (reference) |
| Sequence / identity | Dual GIP / GLP-1 receptor agonist peptide (research material) |
| Intended use | In vitro laboratory research only (RUO) |
Tirzepatide is supplied strictly for research use in metabolic and dual-agonist pathway models. Specs are lot-dependent; request CoA documentation for analytical details. Not intended for human consumption or clinical use.
Content is for scientific reference only and does not constitute medical advice or instructions for human use.
Long-acting GLP-1 receptor agonist analog supplied for metabolic pathway and incretin-signaling research models.
Investigational triple-agonist peptide for laboratory metabolic pathway research in model systems.